Items where authors include "Cooper, A"

Article

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Cooper, A, Turney, CSM, Palmer, J et al. (30 more authors) (2021) A global environmental crisis 42,000 years ago. Science, 371 (6531). pp. 811-818. ISSN 0036-8075

Tarn, JR, Howard-Tripp, N, Lendrem, DW et al. (48 more authors) (2019) Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials. The Lancet Rheumatology, 1 (2). e85-e94. ISSN 2665-9913

Hackett, KL, Davies, K, Tarn, J et al. (32 more authors) (2019) Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren's syndrome. RMD Open, 5 (1). e000885. ISSN 2056-5933

Marshall, I, Thrippleton, MJ, Bastin, ME et al. (16 more authors) (2018) Characterisation of tissue-type metabolic content in secondary progressive multiple sclerosis: a magnetic resonance spectroscopic imaging study. Journal of Neurology, 265 (8). pp. 1795-1802. ISSN 0340-5354

Dumusc, A, Ng, W-F, James, K et al. (27 more authors) (2018) Comparison of ESSDAI and ClinESSDAI in potential optimization of trial outcomes in primary Sjögren’s syndrome: examination of data from the UK Primary Sjögren’s Syndrome Registry. Swiss Medical Weekly, 148 (56). w14588. ISSN 1424-7860

Oni, C, Mitchell, S, James, K et al. (31 more authors) (2017) Eligibility for clinical trials in primary Sjögren’s syndrome: lessons from the UK Primary Sjögren’s Syndrome Registry. Rheumatology, 56 (12). p. 2255. ISSN 1462-0324

Tillett, W, Shaddick, G, Jobling, A et al. (14 more authors) (2017) Effect of anti-TNF and conventional synthetic disease-modifying anti-rheumatic drug treatment on work disability and clinical outcome in a multicentre observational cohort study of psoriatic arthritis. Rheumatology, 56 (4). kew433. pp. 603-612. ISSN 1462-0324

Ng, W-F, Miller, A, Bowman, SJ et al. (26 more authors) (2017) Physical activity but not sedentary activity is reduced in primary Sjögren’s syndrome. Rheumatology International, 37 (4). pp. 623-631. ISSN 0172-8172

Howard Tripp, N, Tarn, J, Natasari, A et al. (29 more authors) (2016) Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines. RMD Open, 2 (2). e000282.

Oni, C, Mitchell, S, James, K et al. (30 more authors) (2016) Eligibility for clinical trials in primary Sjögren’s syndrome: lessons from the UK Primary Sjögren’s Registry (UKPSSR). Rheumatology, 55 (3). pp. 544-552. ISSN 1462-0324

Lendrem, D, Mitchell, S, McMeekin, P et al. (28 more authors) (2015) Do the EULAR Sjögren’s syndrome outcome measures correlate with health status in primary Sjögren’s syndrome? Rheumatology, 54 (4). pp. 655-659. ISSN 1462-0324

Monograph

Dowling, D, Melly, F, Boyle, D et al. (7 more authors) (2022) Accelerating Net Zero Delivery Unlocking the benefits of climate action in UK city-regions. Report.